Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 6056-6063

  Dang, MyLinh ^a   Rockell, Jennifer ^a   Wagner, Rebecca ^a   Wenzlau, Janet M ^a   Yu, Liping ^a   Hutton, John C ^a   Gottlieb, Peter A ^a   Davidson, Howard W ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

ADULT; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNITY; CELL STIMULATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE LIBRARY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; T LYMPHOCYTE;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNITY; CATION TRANSPORT PROTEINS; CHILD; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; GENOTYPE; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; INTERFERON-GAMMA; MALE; T-LYMPHOCYTES;

EID: 79956218486     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003815     Document Type: Article

References (38)

1. Monti, P., A. K. Heninger, and E. Bonifacio. 2009. Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus. Curr. Diab. Rep. 9: 113-118.
2. Di Lorenzo, T. P., M. Peakman, and B. O. Roep. 2007. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 148: 1-16.
3. Honeyman, M. C., N. L. Stone, B. A. Falk, G. Nepom, and L. C. Harrison. 2010. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J. Immunol. 184: 2204-2210.
4. Tree, T. I., and M. Peakman. 2004. Autoreactive T cells in human type 1 diabetes. Endocrinol. Metab. Clin. North Am. 33: 113-133, ix-x.
5. Chimienti, F., S. Devergnas, A. Favier, and M. Seve. 2004. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53: 2330-2337. (Pubitemid 39145586)
6. Wenzlau, J. M., K. Juhl, L. Yu, O. Moua, S. A. Sarkar, P. Gottlieb, M. Rewers, G. S. Eisenbarth, J. Jensen, H. W. Davidson, and J. C. Hutton. 2007. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 104: 17040-17045.
7. Achenbach, P., V. Lampasona, U. Landherr, K. Koczwara, S. Krause, H. Grallert, C. Winkler, M. Pflüger, T. Illig, E. Bonifacio, and A. G. Ziegler. 2009. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52: 1881-1888.
8. Kawasaki, E., M. Uga, K. Nakamura, G. Kuriya, T. Satoh, K. Fujishima, M. Ozaki, N. Abiru, H. Yamasaki, J. M. Wenzlau, et al. 2008. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 51: 2299-2302.
9. Lampasona, V., A. Petrone, C. Tiberti, M. Capizzi, M. Spoletini, S. di Pietro, M. Songini, S. Bonicchio, F. Giorgino, E. Bonifacio, et al; Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group. 2010. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care 33: 104-108.
10. De Grijse, J., M. Asanghanwa, B. Nouthe, N. Albrecher, P. Goubert, I. Vermeulen, S. Van Der Meeren, K. Decochez, I. Weets, B. Keymeulen, et al; Belgian Diabetes Registry. 2010. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 53: 517-524.
11. Hummel, M., I. Durinovic-Bello, and A. G. Ziegler. 1996. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J. Autoimmun. 9: 427-430.
12. Herold, K. C., B. Brooks-Worrell, J. Palmer, H. M. Dosch, M. Peakman, P. Gottlieb, H. Reijonen, S. Arif, L. M. Spain, C. Thompson, J. M. Lachin; Type 1 Diabetes TrialNet Research Group. 2009. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 58: 2588-2595.
13. Nagata, M., R. Kotani, H. Moriyama, K. Yokono, B. O. Roep, and M. Peakman. 2004. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop. Ann. N. Y. Acad. Sci. 1037: 10-15.
14. Arif, S., T. I. Tree, T. P. Astill, J. M. Tremble, A. J. Bishop, C. M. Dayan, B. O. Roep, and M. Peakman. 2004. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113: 451-463.
15. Gianani, R., D. U. Rabin, C. F. Verge, L. Yu, S. R. Babu, M. Pietropaolo, and G. S. Eisenbarth. 1995. ICA512 autoantibody radioassay. Diabetes 44: 1340-1344.
16. Falorni, A., E. Ortqvist, B. Persson, and A. Lernmark. 1995. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J. Immunol. Methods 186: 89-99.
17. Yu, L., D. T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G. S. Eisenbarth. 2000. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. USA 97: 1701-1706.
18. Erlich, H. A., G. Opelz, and J. Hansen. 2001. HLA DNA typing and transplantation. Immunity 14: 347-356. (Pubitemid 32441587)
19. Kwok, W. W., S. Kovats, P. Thurtle, and G. T. Nepom. 1993. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation. J. Immunol. 150: 2263-2272.
20. Brooks-Worrell, B., A. Warsen, and J. P. Palmer. 2009. Improved T cell assay for identification of type 1 diabetes patients. J. Immunol. Methods 344: 79-83.
21. Brooks-Worrell, B. M., G. A. Starkebaum, C. Greenbaum, and J. P. Palmer. 1996. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J. Immunol. 157: 5668-5674.
22. Jahromi, M. M., and G. S. Eisenbarth. 2006. Genetic determinants of type 1 diabetes across populations. Ann. N. Y. Acad. Sci. 1079: 289-299.
23. Nepom, G. T. 1990. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39: 1153-1157. (Pubitemid 20327048)
24. Sheehy, M. J. 1992. HLA and insulin-dependent diabetes. A protective perspective. Diabetes 41: 123-129.
25. Whitacre, C. C. 2001. Sex differences in autoimmune disease. Nat. Immunol. 2: 777-780.
26. Narendran, P., A. J. Williams, K. Elsegood, N. J. Leech, and C. M. Dayan. 2003. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes. Diabetes Metab. Res. Rev. 19: 52-59.
27. Campbell, D. J., C. H. Kim, and E. C. Butcher. 2001. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2: 876-881.
28. Hawkes, C. J., N. C. Schloot, J. Marks, S. J. Willemen, J. W. Drijfhout, E. K. Mayer, M. R. Christie, and B. O. Roep. 2000. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49: 356-366.
29. Meierhoff, G., P. A. Ott, P. V. Lehmann, and N. C. Schloot. 2002. Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetes. Diabetes Metab. Res. Rev. 18: 367-380.
30. Li, L., Q. He, A. Garland, Z. Yi, L. T. Aybar, T. B. Kepler, J. A. Frelinger, B. Wang, and R. Tisch. 2009. b cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. J. Immunol. 183: 7585-7591.
31. Wong, C. P., R. Stevens, B. Long, L. Li, Y. Wang, M. A. Wallet, K. S. Goudy, J. A. Frelinger, and R. Tisch. 2007. Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets. J. Immunol. 178: 1388-1395. (Pubitemid 46154609)
32. Guermonprez, P., and S. Amigorena. 2005. Pathways for antigen cross presentation. Springer Semin. Immunopathol. 26: 257-271.
33. Mathis, D., and C. Benoist. 2009. Aire. Annu. Rev. Immunol. 27: 287-312.
34. Peterson, P., T. Org, and A. Rebane. 2008. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat. Rev. Immunol. 8: 948-957.
35. Yip, L., L. Su, D. Sheng, P. Chang, M. Atkinson, M. Czesak, P. R. Albert, A. R. Collier, S. J. Turley, C. G. Fathman, and R. J. Creusot. 2009. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nat. Immunol. 10: 1026-1033.
36. Derbinski, J., J. Gäbler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn, L. Peltonen, J. Walter, and B. Kyewski. 2005. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202: 33-45.
37. Ott, P. A., M. T. Dittrich, B. A. Herzog, R. Guerkov, P. A. Gottlieb, A. L. Putnam, I. Durinovic-Bello, B. O. Boehm, M. Tary-Lehmann, and P. V. Lehmann. 2004. T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J. Clin. Immunol. 24: 327-339.
38. Herzog, B. A., P. A. Ott, M. T. Dittrich, S. Quast, A. Y. Karulin, H. Kalbacher, W. Karges, M. Tary-Lehmann, P. V. Lehmann, B. O. Boehm, and I. Durinovic-Belló. 2004. Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects. J. Autoimmun. 23: 45-54. (Pubitemid 38953792)